Innovus Pharmaceuticals 10-Q 2010 Q1 Quarterly report

EXHIBIT 32.1

Section 1350 Certification

In connection with the Report of North Horizon, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2010 as filed with the Securities and Exchange Commission (the “Report”), I, Wallace Boyack, Chief Executive Officer and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. SS. 1350, as adopted pursuant to SS. 906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and

2. The information contained in the Report fairly presents, in all material respects, the financial conditions and results of operations of the Company.

Date: May 12, 2010	By:	/s/Wallace Boyack
		Wallace Boyack
		Chief Executive Officer, principal executive officer